300x Faster Genomics with Dayhoff Powered by AMD GPUs

Genomics has no shortage of data.

What it lacks, at the clinical and research scale, is time.

Across whole genome sequencing (WGS), single-cell sequencing (SCS), and microbiome analysis, the volume of raw sequencing data has grown exponentially. Yet for many organizations, the bottleneck is no longer sequencing itself. It’s secondary analysis: alignment, variant calling, database querying, and taxonomy assignment.

These workflows are computationally intensive and frequently memory-bound. Traditional CPU-based systems struggle to keep pace without significant infrastructure expansion, energy consumption, and turnaround delays.

In partnership with AMD, Dayhoff Health set out to test whether modern GPU architecture could fundamentally change that equation.

The results demonstrate a step change in genomics performance, moving from hours to seconds at production scale. 

The Real Bottleneck in Genomics

Genomics workflows typically involve three phases:

1. Primary sequencing
2. Secondary analysis (alignment, sorting, variant calling, database queries)
3. Tertiary interpretation

Secondary analysis is where infrastructure pressure builds.

Tasks such as:

• Whole genome alignment (e.g., BWA-MEM)
• Variant calling (e.g., HaplotypeCaller)
• Single-cell barcode matching and UMI deduplication
• Microbiome taxonomy assignment via k-mer database matching requires billions of repeated operations across large datasets.

While CPUs offer flexibility, they are constrained by shared system memory bandwidth, typically around 100 GB/s, and are subject to memory pressure, disk swapping, and OS contention.

Modern genomics pipelines demand a different architecture.

Why GPUs and Why Now

AMD GPUs, powered by the ROCm™ open software platform and the HIP programming model, offer:

• Massive parallelism (thousands of concurrent threads)
• 576 GB/s of dedicated memory bandwidth
• Dedicated 32GB GPU VRAM, eliminating system memory contention
• An open, portable ecosystem without vendor lock-in

Genomics workloads, particularly memory-bound database queries, map naturally to this architecture.

To validate this at scale, Dayhoff Health partnered with AMD to test our production genomics and microbiome analysis platform in handling real-world clinical and wellness workloads.

Validating Real-World Genomics Workloads

Testing was conducted using an AMD Radeon™ R9700 GPU (gfx1201, RDNA3 architecture) running ROCm™ 7.0.2, compared against a CPU baseline (AMD Ryzen™ 7950X).

The workloads included:

• 50x coverage whole genome sequencing (~150GB raw data)
• Single-cell RNA sequencing (~300 million reads)
• Clinical-scale microbiome analysis (~30 million reads, 80GB Kraken2 database)

Accuracy validation showed >99% concordance between CPU and GPU outputs.

The performance results were significant.

330× Faster Microbiome Analysis

Microbiome taxonomy assignment is heavily memory-bound. Each sample requires billions of database lookups across large k-mer datasets.

In Dayhoff Health’s production workflow:

• CPU baseline (unoptimized): 264 seconds
• CPU under memory pressure: degraded to 774 seconds
• AMD GPU (R9700): 0.8 seconds end-to-end

Speedup: 330× (and up to 968× under degraded CPU conditions).

Why the difference?

• GPU memory bandwidth: 576 GB/s
• CPU shared memory bandwidth: ~100 GB/s
• Dedicated VRAM prevents disk swapping
• 70% sustained memory bandwidth utilization during database queries

This shift moves microbiome processing from overnight batch workflows to real-time execution, enabling interactive clinical and research applications.

Whole Genome and Single-Cell Acceleration

While microbiome workloads are primarily memory-bound, WGS and SCS pipelines combine compute- and memory-intensive tasks.

Results included:

Whole Genome Sequencing (50x coverage)

• CPU: 9–11 hours
• GPU: 30–45 minutes
• Speedup: 13–22×

Single-Cell RNA Sequencing

• CPU: 12–14 hours
• GPU: 30–40 minutes
• Speedup: 18–28×

In these workloads, GPU acceleration leveraged:

• 3,840 concurrent threads
• Optimized wavefront scheduling (RDNA3)
• High memory bandwidth for sorting and alignment
• Efficient parallel barcode matching and UMI deduplication

The combined impact reduces turnaround from overnight to same-day analysis.

Memory Bandwidth as the Limiting Factor

One of the clearest findings from this collaboration is that memory bandwidth is often the limiting factor in genomics.

Key observations:

• CPU performance degraded 3× under memory pressure
• GPU maintained stable throughput due to dedicated VRAM
• Memory-bound algorithms achieved the highest acceleration (up to 330×)
• Compute-bound operations saw 20–40× improvements

This reinforces a critical design principle: genomics workloads are not simply “faster CPUs” problems; they are architectural problems.

AMD GPUs are purpose-built for these patterns.

From Infrastructure to Impact

Performance improvements of this magnitude do more than shorten runtimes.

They enable new operational models:

• Real-time microbiome diagnostics
• Same-day genomic variant reporting
• Dramatic increases in daily sample throughput
• Reduced infrastructure footprint compared to large CPU clusters
• Lower energy consumption (165W GPU vs. 250W+ CPU cluster equivalents)

By partnering with AMD, Dayhoff Health validated these capabilities against real production pipelines.

As noted by Dayhoff Health’s CEO:

“For the first time, we can process genomic data as fast as care decisions happen. AMD not only made our platform faster, they also made a new operating model possible.” - Roozbeh Ebbadi

The Future of Life Sciences Computing

As genomics data continues to expand across research institutions, healthcare systems, and emerging clinical applications, infrastructure must evolve accordingly.

Open ecosystems, architectural efficiency, and memory bandwidth matter.

The collaboration between AMD and Dayhoff Health demonstrates that real-time genomics is not theoretical. It is achievable today with the right compute platform.

To learn more about the technical details, performance methodology, and architecture behind these results, read the full white paper.

Interested in offering a preventative health wellness program for your workforce?